Cargando…

Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure

OBJECTIVE: To analyse the guiding value of procalcitonin (PCT) for the selection of ventilation switching points in sequential mechanical ventilation for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and respiratory failure, and to provide a reference for the optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Fang, Liu, Wenjing, Wang, Huiqing, Wang, Weiwei, Yang, Caixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587698/
https://www.ncbi.nlm.nih.gov/pubmed/36281227
http://dx.doi.org/10.2147/COPD.S366028
_version_ 1784813965067419648
author Ding, Fang
Liu, Wenjing
Wang, Huiqing
Wang, Weiwei
Yang, Caixia
author_facet Ding, Fang
Liu, Wenjing
Wang, Huiqing
Wang, Weiwei
Yang, Caixia
author_sort Ding, Fang
collection PubMed
description OBJECTIVE: To analyse the guiding value of procalcitonin (PCT) for the selection of ventilation switching points in sequential mechanical ventilation for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and respiratory failure, and to provide a reference for the optimisation of mechanical ventilation for patients with COPD and respiratory failure. METHODS: The study included 160 patients with an acute exacerbation of COPD complicated by respiratory failure who received sequential mechanical ventilation treatment. They were divided into two groups of 80 participants. The critical point of the pulmonary infection observation window (PIC) was used as the switching point for sequential mechanical ventilation treatment in the control group, and PCT clinical node was used as the switching point for sequential mechanical ventilation treatment in the observation group. The invasive ventilation time, non-invasive mechanical ventilation time, total mechanical ventilation time, intensive care unit (ICU) treatment time, complication rate and prognosis were compared for the two groups. RESULTS: (1) There was no significant difference in the respiratory rate, heart rate, arterial systolic pressure, arterial oxygen partial pressure, arterial carbon dioxide partial pressure or pH value between the two groups after 1 day of treatment, and (2) invasive mechanical ventilation time, non-invasive mechanical ventilation time, total mechanical ventilation time, ICU treatment time and the incidence of complications were significantly different in the two groups (P = 0.0001). CONCLUSION: Detecting PCT can guide the selection of ventilation switching points in sequential mechanical ventilation therapy for patients with COPD with respiratory failure in the acute exacerbation stage, effectively reduce the misevaluation of PIC switching points so that patients can obtain stable criteria for judgement and effectively improve the efficiency and safety of mechanical ventilation treatment for patients in the acute exacerbation stage.
format Online
Article
Text
id pubmed-9587698
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95876982022-10-23 Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure Ding, Fang Liu, Wenjing Wang, Huiqing Wang, Weiwei Yang, Caixia Int J Chron Obstruct Pulmon Dis Original Research OBJECTIVE: To analyse the guiding value of procalcitonin (PCT) for the selection of ventilation switching points in sequential mechanical ventilation for patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and respiratory failure, and to provide a reference for the optimisation of mechanical ventilation for patients with COPD and respiratory failure. METHODS: The study included 160 patients with an acute exacerbation of COPD complicated by respiratory failure who received sequential mechanical ventilation treatment. They were divided into two groups of 80 participants. The critical point of the pulmonary infection observation window (PIC) was used as the switching point for sequential mechanical ventilation treatment in the control group, and PCT clinical node was used as the switching point for sequential mechanical ventilation treatment in the observation group. The invasive ventilation time, non-invasive mechanical ventilation time, total mechanical ventilation time, intensive care unit (ICU) treatment time, complication rate and prognosis were compared for the two groups. RESULTS: (1) There was no significant difference in the respiratory rate, heart rate, arterial systolic pressure, arterial oxygen partial pressure, arterial carbon dioxide partial pressure or pH value between the two groups after 1 day of treatment, and (2) invasive mechanical ventilation time, non-invasive mechanical ventilation time, total mechanical ventilation time, ICU treatment time and the incidence of complications were significantly different in the two groups (P = 0.0001). CONCLUSION: Detecting PCT can guide the selection of ventilation switching points in sequential mechanical ventilation therapy for patients with COPD with respiratory failure in the acute exacerbation stage, effectively reduce the misevaluation of PIC switching points so that patients can obtain stable criteria for judgement and effectively improve the efficiency and safety of mechanical ventilation treatment for patients in the acute exacerbation stage. Dove 2022-10-18 /pmc/articles/PMC9587698/ /pubmed/36281227 http://dx.doi.org/10.2147/COPD.S366028 Text en © 2022 Ding et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ding, Fang
Liu, Wenjing
Wang, Huiqing
Wang, Weiwei
Yang, Caixia
Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title_full Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title_fullStr Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title_full_unstemmed Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title_short Guidance Value of Procalcitonin Detection in Selecting Switching Points for Sequential Therapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure
title_sort guidance value of procalcitonin detection in selecting switching points for sequential therapy in patients with acute exacerbation of chronic obstructive pulmonary disease complicated by respiratory failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587698/
https://www.ncbi.nlm.nih.gov/pubmed/36281227
http://dx.doi.org/10.2147/COPD.S366028
work_keys_str_mv AT dingfang guidancevalueofprocalcitonindetectioninselectingswitchingpointsforsequentialtherapyinpatientswithacuteexacerbationofchronicobstructivepulmonarydiseasecomplicatedbyrespiratoryfailure
AT liuwenjing guidancevalueofprocalcitonindetectioninselectingswitchingpointsforsequentialtherapyinpatientswithacuteexacerbationofchronicobstructivepulmonarydiseasecomplicatedbyrespiratoryfailure
AT wanghuiqing guidancevalueofprocalcitonindetectioninselectingswitchingpointsforsequentialtherapyinpatientswithacuteexacerbationofchronicobstructivepulmonarydiseasecomplicatedbyrespiratoryfailure
AT wangweiwei guidancevalueofprocalcitonindetectioninselectingswitchingpointsforsequentialtherapyinpatientswithacuteexacerbationofchronicobstructivepulmonarydiseasecomplicatedbyrespiratoryfailure
AT yangcaixia guidancevalueofprocalcitonindetectioninselectingswitchingpointsforsequentialtherapyinpatientswithacuteexacerbationofchronicobstructivepulmonarydiseasecomplicatedbyrespiratoryfailure